Nemaura Medical Inc.
NMRDDelisted Mar 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001602078
Nemaura Medical Inc. was delisted on Mar 21, 2024; its insiders filed their last Form 4 on Jan 9, 2024; 21 institutions reported holding it in 13F filings for Q4 2023, worth $280.9K in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Nemaura Medical Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NMRD is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023
- Institutional holders
- 2
- −19 vs. Q4 2023
- Shares held
- 20.8K
- −1.26M (−98.4%) vs. Q4 2023
- Total value
- $1.85K
- −$279.0K (−99.3%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 19
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $1.85K |
| Q4 2023 | 21 | $280.9K |
| Q3 2023 | 22 | $698.6K |
| Q2 2023 | 15 | $2.61M |
| Q1 2023 | 16 | $2.88M |
| Q4 2022 | 16 | $1.39M |
| Q3 2022 | 20 | $1.71M |
| Q2 2022 | 19 | $2.16M |
| Q1 2022 | 17 | $3.70M |
| Q4 2021 | 17 | $2.29M |
| Q3 2021 | 17 | $3.62M |
| Q2 2021 | 29 | $10.8M |
| Q1 2021 | 30 | $8.29M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Nemaura Medical Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| XTX Topco Ltd | 18,874 | $1.68K | 0.00% | −2,454−11.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 1,950 | $174 | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −845,060−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −126,682−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −107,897−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −53,666−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −41,693−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −26,737−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,403−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −13,926−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −11,872−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −4,163−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −3,542−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Salomon & Ludwin, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Hazlett, Burt & Watson, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |